CPHI
China Pharma Holdings·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 0
Bearish signal 1
Consecutive Revenue Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CPHI
China Pharma Holdings, Inc.
A Chinese pharmaceutical company that develops, manufactures, and markets specialty pharmaceutical products in China
Pharmaceutical
01/28/1999
09/30/2009
American Stock Exchange
231
12-31
Common stock
Second Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216
Drug development, production and sales
Established on January 28, 1999, China National Pharmaceutical Holdings Co., Ltd. is a modern pharmaceutical enterprise integrating drug R & D, production and sales. The company is mainly engaged in the development, production and sales of various pharmaceutical products with high morbidity and mortality. At present, the company has a diversified product portfolio, focusing on the treatment of central nervous system diseases, cardiovascular and cerebrovascular diseases and anti-infective diseases.
Company Financials
EPS
CPHI has released its 2025 Q2 earnings. EPS was reported at -0.16, versus the expected 0, missing expectations. The chart below visualizes how CPHI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CPHI has released its 2025 Q2 earnings report, with revenue of 1.03M, reflecting a YoY change of 10.90%, and net profit of -528.37K, showing a YoY change of 63.26%. The Sankey diagram below clearly presents CPHI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
